Amicus therapeutics, inc. (FOLD)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

123,231

142,837

166,319

220,578

96,300

79,749

201,827

73,311

114,322

49,060

64,133

37,394

44,755

187,026

33,115

63,656

23,510

69,485

19,439

249,023

28,827

24,074

19,671

41,904

27,533

43,640

30,047

23,476

26,736

33,971

24,273

28,858

24,523

25,668

22,810

25,789

29,572

Investments in marketable securities

215,642

309,903

347,875

355,078

341,978

424,403

362,556

465,641

448,198

309,502

347,388

189,838

235,087

143,325

179,284

150,494

142,341

144,548

217,070

112,396

119,940

127,601

65,511

36,092

44,121

38,360

30,448

50,700

58,015

65,151

81,942

66,914

83,673

30,034

46,718

57,257

77,873

Accounts receivable

40,555

33,284

33,731

28,709

22,960

21,962

14,189

15,077

10,836

9,464

5,974

3,786

1,875

1,304

864

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

12,831

14,041

9,154

10,395

8,167

8,390

6,311

7,769

8,070

4,623

7,272

3,948

3,698

3,416

3,251

194

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

15,690

20,008

19,578

20,116

13,592

16,592

16,151

14,432

10,607

19,316

6,246

6,023

10,792

4,993

5,198

3,330

2,662

2,568

3,544

3,578

2,484

2,902

1,762

951

1,758

5,195

1,692

1,978

1,753

2,270

3,077

2,658

2,789

5,903

3,038

3,076

2,236

Receivable due from collaboration agreements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

293

475

38

1,083

2,121

1,024

1,308

3,225

3,184

7,237

4,301

5,043

3,828

1,977

0

Total current assets

407,949

520,073

576,657

634,876

483,046

551,096

601,034

576,230

592,033

391,965

431,013

240,989

296,207

340,064

221,712

217,674

168,513

216,601

240,053

364,997

151,251

154,577

87,237

79,422

73,450

88,278

64,308

77,178

87,812

104,617

112,476

105,667

115,286

66,648

76,394

88,099

109,681

Operating lease right-of-use assets, less accumulated amortization of $6,260 and $5,342 at March 31, 2020 and December 31, 2019, respectively

32,501

33,315

35,814

35,052

36,308

-

-

13,836

42,673

-

15,109

-

-

-

-

-

-

-

15,428

-

2,804

17,464

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, less accumulated depreciation of $19,260 and $17,604 at March 31, 2020 and December 31, 2019, respectively

47,688

47,705

34,673

15,273

13,286

11,375

10,659

9,111

8,910

9,062

9,641

10,471

9,745

9,816

10,183

10,178

8,413

6,178

3,855

3,379

3,056

2,811

3,129

3,444

3,748

4,120

4,356

4,715

4,962

5,029

5,293

5,489

5,073

2,438

1,759

1,922

2,604

In-process research & development

23,000

23,000

23,000

23,000

23,000

23,000

23,000

23,000

23,000

23,000

23,000

486,700

486,700

486,700

486,700

486,700

486,700

486,700

518,810

23,000

23,000

23,000

23,000

23,000

23,000

23,000

-

-

-

-

-

-

-

-

-

-

-

Goodwill

197,797

197,797

197,797

197,797

197,797

197,800

197,797

197,797

197,797

197,800

197,797

197,797

197,797

197,797

197,797

197,797

197,797

197,797

207,564

11,613

11,613

11,613

11,613

11,613

11,613

11,613

-

-

-

-

-

-

-

-

-

-

-

Other non-current assets

29,414

28,317

14,351

12,035

11,265

6,683

6,099

5,915

5,592

5,200

4,219

3,009

2,932

2,468

1,788

1,657

1,484

1,108

982

924

892

502

508

515

546

552

442

442

442

442

442

442

442

709

714

267

267

Total Assets

738,349

850,207

882,292

918,033

764,702

789,951

838,589

825,889

870,005

627,024

680,779

938,966

993,381

1,036,845

918,180

914,006

862,907

908,384

986,692

403,913

192,616

209,967

125,487

117,994

112,357

127,563

69,106

82,335

93,216

110,088

118,211

111,598

120,801

69,795

78,867

90,288

112,552

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

16,239

21,722

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other current liabilities

66,722

98,651

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses, and other current liabilities

-

-

81,475

84,119

60,596

80,625

54,330

41,613

43,678

53,890

53,709

35,645

39,645

41,008

29,013

23,828

22,501

32,216

30,565

16,901

15,833

16,345

11,331

9,918

9,167

10,162

8,166

9,018

6,427

8,845

9,428

9,067

8,449

9,708

8,098

7,019

8,290

Deferred reimbursements

1,250

1,250

5,250

2,750

2,750

5,500

2,750

2,750

7,750

7,750

6,250

18,850

13,850

13,850

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,504

-

-

-

Operating lease liabilities

7,503

7,189

6,356

2,678

2,523

-

-

-

80,577

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

40

Current portion of deferred reimbursements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,929

8,187

-

9,274

8,606

6,640

Current portion of secured loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,189

3,840

2,493

1,253

199

299

398

398

398

398

502

816

1,129

1,044

1,253

1,253

1,253

Contingent consideration payable

-

-

-

-

-

-

8,800

8,600

8,700

8,400

8,200

46,188

56,101

56,101

55,992

56,000

41,926

41,400

5,300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

607

631

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

91,714

128,812

93,081

89,547

65,869

86,125

65,880

52,963

140,705

70,040

68,159

100,683

109,596

110,959

85,612

80,459

64,427

73,616

35,865

16,901

21,022

20,185

13,824

11,171

9,366

10,461

8,598

9,967

7,995

9,243

9,930

17,812

17,765

19,256

18,625

16,878

16,223

Deferred reimbursements

8,906

8,906

8,906

11,406

11,406

10,156

14,156

14,156

14,156

14,156

16,906

16,906

21,906

21,906

35,756

35,756

35,756

35,756

36,620

36,620

36,620

36,620

36,677

36,677

36,677

36,677

34,019

32,709

31,685

30,418

27,235

-

-

18,999

-

-

-

Convertible notes

2,167

2,131

2,096

2,070

22,052

175,006

172,186

169,440

166,768

164,167

161,635

159,171

156,859

154,464

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44,047

43,443

-

41,601

50,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34

551

1,170

908

-

-

4,324

-

2,690

6,066

4,712

Senior secured term loan

147,569

147,374

147,164

146,994

146,766

146,734

146,622

-

-

0

-

-

-

-

-

-

-

-

-

-

9,208

10,510

11,809

13,104

14,216

14,174

-

100

199

299

398

498

597

-

104

418

1,044

Unsecured notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,977

21,851

38,509

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration payable

23,612

22,681

22,036

21,247

20,767

19,700

19,300

18,200

17,800

17,000

12,900

219,162

218,199

213,621

216,198

220,300

235,303

232,677

277,684

11,800

11,700

10,700

10,200

10,800

11,105

10,600

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

5,051

5,051

6,465

6,465

6,465

6,465

6,465

6,465

6,465

6,465

9,186

173,869

173,820

173,771

176,219

176,219

176,219

176,219

207,213

9,186

9,186

9,186

9,186

9,186

9,186

9,186

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

52,522

53,531

49,686

36,259

36,100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

4,214

5,296

4,591

3,987

3,609

2,853

3,029

2,770

2,494

2,346

2,313

2,283

2,223

1,973

1,816

1,735

1,061

681

555

504

870

588

514

748

723

714

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

335,755

373,782

334,025

317,975

313,034

447,039

427,638

263,994

348,388

274,174

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Common stock, $0.01 par value, 500,000,000 shares authorized, 257,449,955 and 255,417,869 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

2,607

2,598

2,591

2,589

2,347

1,942

1,941

1,939

1,929

1,721

1,707

1,485

1,482

1,480

1,478

1,399

1,308

1,306

1,304

1,241

1,024

1,015

853

789

703

679

556

556

556

556

554

524

524

407

407

406

406

Additional paid-in capital

2,238,346

2,227,225

2,210,890

2,201,447

1,970,607

1,740,061

1,731,174

1,723,865

1,621,479

1,400,758

1,387,767

1,132,229

1,126,148

1,120,156

1,038,613

990,032

921,234

917,454

914,263

826,582

574,757

568,743

468,650

444,600

424,844

423,593

392,213

390,696

389,113

387,539

385,042

365,210

363,456

299,285

297,849

295,898

290,248

Accumulated other comprehensive loss:
Foreign currency translation adjustment

6,981

2,785

1,156

352

-1,309

495

-875

-1,539

-3,847

-1,659

-1,367

-192

1,487

1,945

1,062

842

-65

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized (loss) gain on available-for-sale securities

-169

40

124

355

157

-427

-211

-455

-877

-436

-101

31

185

102

287

201

114

-115

-142

-52

-35

-132

2

-2

2

1

5

3

15

14

37

17

37

4

-25

-14

-28

Deferred revenue, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,679

17,339

-

20,659

22,319

25,639

Warrants

12,387

12,387

12,387

12,387

12,387

13,063

13,063

13,063

16,076

16,076

16,076

16,076

16,076

16,076

16,076

16,076

12,298

8,755

-

-

-

-

-

-

-

-

-

-

-

-

3,889

4,442

-

1,948

-

-

-

Accumulated deficit

-1,900,000

-1,768,610

-1,700,000

-1,600,000

-1,532,521

-1,412,222

-1,334,141

-1,174,978

-1,113,143

-1,063,610

-994,402

-882,737

-834,600

-779,608

-720,961

-674,307

-623,257

-579,566

-536,670

-498,869

-471,736

-447,448

-426,228

-409,079

-394,465

-378,522

-366,285

-351,696

-336,347

-318,889

-308,874

-292,584

-283,241

-270,104

-261,442

-251,683

-225,692

Total stockholders’ equity

402,594

476,425

548,267

600,058

451,668

342,912

410,951

561,895

521,617

352,850

409,680

266,892

310,778

360,151

336,555

334,243

311,632

347,834

378,755

328,902

104,010

122,178

43,277

36,308

31,084

45,751

26,489

39,559

53,337

69,220

76,759

73,167

80,776

29,592

36,789

44,607

64,934

Total Liabilities and Stockholders’ Equity

738,349

850,207

882,292

918,033

764,702

789,951

838,589

825,889

870,005

627,024

680,779

938,966

993,381

1,036,845

918,180

914,006

862,907

908,384

986,692

403,913

192,616

209,967

125,487

117,994

112,357

127,563

69,106

82,335

93,216

110,088

118,211

111,598

120,801

69,795

78,867

90,288

112,552